APA (7th ed.) Citation

G, V., CS, L., TM, G., MB, M., CG, N., MH, H., & TS, L. (2025). Multilevel Analysis of MYC and BCL2 Aberrations in Diffuse Large B-Cell Lymphoma: Identifying a High-Risk Patient Subgroup Across Cell-of-Origin Using Targeted Sequencing. European journal of haematology, 114(3), 469. https://doi.org/10.1111/ejh.14345

Chicago Style (17th ed.) Citation

G, Vimalathas, Lang CS, Green TM, Møller MB, Nyvold CG, Hansen MH, and Larsen TS. "Multilevel Analysis of MYC and BCL2 Aberrations in Diffuse Large B-Cell Lymphoma: Identifying a High-Risk Patient Subgroup Across Cell-of-Origin Using Targeted Sequencing." European Journal of Haematology 114, no. 3 (2025): 469. https://doi.org/10.1111/ejh.14345.

MLA (9th ed.) Citation

G, Vimalathas, et al. "Multilevel Analysis of MYC and BCL2 Aberrations in Diffuse Large B-Cell Lymphoma: Identifying a High-Risk Patient Subgroup Across Cell-of-Origin Using Targeted Sequencing." European Journal of Haematology, vol. 114, no. 3, 2025, p. 469, https://doi.org/10.1111/ejh.14345.